Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pazopanib versus methotrexate + vinblastine in desmoid tumor
2011-006037-42Phase 2Completed
- Sponsor
- Institut Bergonié
- Start
- Aug 2012
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of pazopanib, methotrexate and vinblastine in aggressive fibromatosis (AF) (2 arms), sponsored by Institut Bergonié. Started Aug 2012; status: completed.
02
Drugs
pazopanibmethotrexatevinblastine
03
Conditions
aggressive fibromatosis (AF)
Beyond the preview
Go deeper on 2011-006037-42.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-006037-42.